BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 10711985)

  • 1. The childhood muscular dystrophies: making order out of chaos.
    Tsao CY; Mendell JR
    Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
    Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
    J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dystrophinopathies, congenital muscular dystrophy, limb-girdle dystrophies: updated classification].
    Teijeira-Bautista S; García-García D; Teijeiro-Ferreira A; Fernández-Hojas R; Fernández-Rodríguez JM; Navarro-Fernández-Balbuena C
    Rev Neurol; 1998 Jun; 26(154):1021-6. PubMed ID: 9658487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminin abnormality in severe childhood autosomal recessive muscular dystrophy.
    Yamada H; Tomé FM; Higuchi I; Kawai H; Azibi K; Chaouch M; Roberds SL; Tanaka T; Fujita S; Mitsui T
    Lab Invest; 1995 Jun; 72(6):715-22. PubMed ID: 7783429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital muscular dystrophy with merosin deficiency.
    Tomé FM; Evangelista T; Leclerc A; Sunada Y; Manole E; Estournet B; Barois A; Campbell KP; Fardeau M
    C R Acad Sci III; 1994 Apr; 317(4):351-7. PubMed ID: 8000914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability.
    Mendell JR; Sahenk Z; Prior TW
    J Child Neurol; 1995 Mar; 10(2):150-9. PubMed ID: 7782608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
    Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
    J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dystroglycan linkage and muscular dystrophy].
    Shimizu T
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries.
    Kirschner J; Bönnemann CG
    Arch Neurol; 2004 Feb; 61(2):189-99. PubMed ID: 14967765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical analysis of human muscular dystrophy.
    Sewry CA
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):142-54. PubMed ID: 10679962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
    Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.
    Voit T; Sewry CA; Meyer K; Hermann R; Straub V; Muntoni F; Kahn T; Unsöld R; Helliwell TR; Appleton R
    Neuropediatrics; 1995 Jun; 26(3):148-55. PubMed ID: 7477753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe childhood autosomal recessive muscular dystrophy].
    Matsumura K; Shimizu T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1422-4. PubMed ID: 8752417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.